pan-Raf inhibitor KIN-2787
Term · Oncology and biomedicine · MLC-T-ONC-015811
An orally available inhibitor of class I, II, and III B-Raf (BRAF) protein kinases, with potential antineoplastic activity. Upon administration, pan-Raf inhibitor KIN-2787 binds to and inhibits Class I, Class II, or Class III B-Raf mutations. This prevents B-Raf-mediated signal transduction pathways, which may lead to an inhibition of tumor growth in B-Raf mutant cells. B-Raf protein kinases play a key role in the RAF/MEK/ERK signaling pathway, which is often deregulated and mutated in human cancers, and plays a key role in tumor cell proliferation and survival.
| Identifier | MLC-T-ONC-015811 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | B-Raf inhibitor KIN-2787 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015811",
"term": "pan-Raf inhibitor KIN-2787",
"field": "Oncology and biomedicine",
"definition": "An orally available inhibitor of class I, II, and III B-Raf (BRAF) protein kinases, with potential antineoplastic activity. Upon administration, pan-Raf inhibitor KIN-2787 binds to and inhibits Class I, Class II, or Class III B-Raf mutations. This prevents B-Raf-mediated signal transduction pathways, which may lead to an inhibition of tumor growth in B-Raf mutant cells. B-Raf protein kinases play a key role in the RAF/MEK/ERK signaling pathway, which is often deregulated and mutated in human cancers, and plays a key role in tumor cell proliferation and survival.",
"synonyms": [
"B-Raf inhibitor KIN-2787"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pan-raf-inhibitor-kin-2787/"
}
Record 12,600 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.